Addition of a neutralizing Gal-9 antibody elicited a 40% decrease in MCP-1 secretion (p < 0.001) as well as a 30% decrease in IL-6 secretion (p < 0.05) in these RA FLS monocultures (Figure 3A and Figure S2). This evidence concerns the gene LGALS9 and rheumatoid arthritis.